Pharma companies – the big R&D spenders

Pharmaceutical companies are thought has rich giants with many resources available to them. However, they optimize manufacturing costs for small molecule chemical entities by outsourcing parts of the manufacturing, forming alliances with chemistry suppliers or basing their operations in low cost countries, like Puerto Rico. This works well for chemistry but for biological entity manufacturing,…

Drug Discovery is obviously expensive but the scientists that actually make the discoveries, make very little money. Yes, they might get a bonus or two but it is nowhere close to what the Vice President of the President of the division will make, who get a decent compensation package with stock options and other bonuses….

An interesting concept is that typically enzymes have been thought of as proteins that have catalytic properties. However, it would be very useful to have catalyst that is not damaged by heat, pH or other proteins that  affect a typical protein. A science that is evolving is to create these novel materials that are different…